Role of endocardial septal ablation in the treatment of hypertrophic obstructive cardiomyopathy.
Anatol J Cardiol
; 16(9): 707-12, 2016 09.
Article
em En
| MEDLINE
| ID: mdl-27609434
ABSTRACT
Septal reduction therapy is accepted as a first therapeutic option for symptomatic drug-resistant hypertrophic obstructive cardiomyopathy (HOCM). Although, surgical septal myectomy is the gold standard method, alcohol septal ablation is a well-studied alternative approach in the patients with suitable anatomy. Endocardial septal ablation (ESA) therapy was relatively new defined modality and outcomes of the procedure were not clearly elucidated yet. We aimed to review the clinical aspects of ESA procedure and provide some historical background.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Cardiomiopatia Hipertrófica
/
Ablação por Cateter
/
Septos Cardíacos
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article